Name: Can-Fite BioPharma
Address: 10 Bareket Street, Petah-Tikva, 49170, ISRAEL
Telephone: +972-3-9241114

Date	Form	Description	Pages
04/21/14	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Documents expand_more EX-99.1	6
04/08/14	F-1	Registration statement for securities of certain foreign private issuers Documents expand_more EX-5.1 EX-23.1	206
03/31/14	20-F	Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Documents expand_more EX-1.1 EX-8.1 EX-12.1 EX-12.2 EX-13.1 EX-13.2	231
03/24/14	D	Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act	6
03/17/14	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Documents expand_more EX-99.1	6
03/10/14	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Documents expand_more EX-99.1 EX-99.2 EX-99.3 EX-99.4 EX-99.5 EX-99.6	126
03/03/14	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Documents expand_more EX-99.1	7
02/25/14	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Documents expand_more EX-99.1	7
02/18/14	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Documents expand_more EX-99.1	7
02/14/14	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Documents expand_more EX-1	7